Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001026027 | SCV001188328 | uncertain significance | Hereditary cancer-predisposing syndrome | 2021-08-10 | criteria provided, single submitter | clinical testing | The c.7092A>G variant (also known as p.A2364A), located in coding exon 48, results from an A to G substitution at nucleotide position 7092 of the ATM gene. This nucleotide substitution does not change the amino acid at codon 2364. This nucleotide position is poorly conserved in available vertebrate species. In silico splice site analysis for this alteration is inconclusive; however, direct evidence is unavailable. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Color Diagnostics, |
RCV001026027 | SCV001351595 | likely benign | Hereditary cancer-predisposing syndrome | 2019-06-24 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001449380 | SCV001652495 | likely benign | Ataxia-telangiectasia syndrome | 2022-03-19 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV004590018 | SCV005083042 | benign | Familial cancer of breast | 2024-06-13 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |